Abnormal activation of PI3K/AKT substantially affects multiple tumors [9], and PI3K/AKT is considered a key pathway in the development of prostate cancer [10], endometrial cancer [11], and laryngeal cancer [12]. Here, AKT1 is linked to laryngeal carcinoma.